Company Overview and News

 
Tudor Gold Appoints Raul Sanabria as Exploration Manager; CHF Capital Markets retained for Investor Relations

2017-05-16 marketwired
VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 16, 2017) - Tudor Gold Corp. (TSX VENTURE:TUD)(FRANKFURT:TUC) (the "Company" or "Tudor Gold") announces that it has appointed Raul Sanabria to head up the exploration programs at their 60% - owned Treaty Creek property and Electrum Project located within the Golden Triangle and in close proximity to some of British Columbia's largest mines.
Upvote Downvote

 
Dotz Nano reveals proof of concept for a new type of flash memory

2017-02-10 proactiveinvestors.com.au
Dotz Nano (ASX:DTZ) has successfully completed a proof of concept research study into the use of Graphene Quantum Dots (GQDs) in flash memory devices with the Kyung Hee University in South Korea.
Upvote Downvote

 
Dotz Nano achieves first sale of graphene quantum dots

2017-01-09 proactiveinvestors.com.au
Dotz Nano is a nano-technology company focusing on the development, manufacture and commercialisation of graphene quantum dots (GQDs). GQDs are used in various applications including medical imaging, sensing, consumer electronics, energy storage, solar cells and computer storage. Strem Chemicals will facilitate sales of Dotz’s GQDs to academic, industrial and government research and development laboratories as well as commercial businesses using GQDs for research purposes.
Upvote Downvote

 
Dotz Nano makes solid ASX debut

2016-11-15 businessnews.com.au
Nano-technology company Dotz Nano has announced plans to establish a $S20 million ($A18.7 million) research centre in Singapore, on the same day it made fruitful gains on its first day of trading on the ASX.
Upvote Downvote

 
Otsana sets up shop in Israel

2016-08-16 businessnews.com.au
West Perth-based advisory firm Otsana Capital has established an office in Israel to work closer with start-ups in the region which are seeking a presence on the ASX.
Upvote Downvote

 
Latin American Appoints Chief Operating Officer to Manage Mining and Processing Operations in Paraguay

2016-07-11 marketwired
TORONTO, ONTARIO--(Marketwired - July 11, 2016) - Latin American Minerals Inc. (TSX VENTURE:LAT) (the "Company" or "LAT") today announced the appointment of Mr. Cameron Tymstra as Chief Operating Officer to oversee the mining and processing operations for the Company's Independencia gold mine in Paso Yobai, Paraguay.
Upvote Downvote

 
Bilbe, Kiernan join local explorers

2016-06-29 businessnews.com.au
Senior mining executives Peter Bilbe and Anthony Kiernan have joined the boards of local exploration companies.
Upvote Downvote

 
Dotz Nano to be 8th Israeli ASX listing

2016-05-23 businessnews.com.au
Listen to podcasts covering breaking news, items of interest and our Success & Leadership Series events. A wide range of topics covered by our well renowned reporters and WA business leaders. Subscribe on iTunes for updates as they happen. Click here for more
Upvote Downvote

 
Northern Iron in backdoor listing

2016-05-23 businessnews.com.au
Listen to podcasts covering breaking news, items of interest and our Success & Leadership Series events. A wide range of topics covered by our well renowned reporters and WA business leaders. Subscribe on iTunes for updates as they happen. Click here for more
Upvote Downvote

 
Results of Meeting

2016-05-13 asx.com.au
Upvote Downvote

 
 
Company Update

2016-04-11 asx.com.au
Upvote Downvote

 

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...